Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

A paper published June 21 in the Journal of the American College of Cardiology details a new alternative training pathway in cardiovascular disease and...

Bina Ahmed, MD,...

In this week’s View, Dr. Eagle discusses the newly published table that lists drug-drug interactions with the anti-viral agent Paxlovid, used in treating COVID-19,...

Medicare drug plans may limit coverage of quadruple drug therapy for heart failure with reduced ejection fraction (HFrEF) through cost sharing, resulting in out-of-pocket...

Debabrata Mukherjee, MD,...

Join Chair Anne Marie Valente, MD, FACC and Chair Emeritus Patrick T. O’Gara, MD, MACC for ACC’s Cardiovascular Overview and Board Prep Virtual Experience!...

Coronary artery disease (CAD) encompasses a spectrum of distinct phenotypes that ranges from obstructive epicardial atherosclerosis to diffuse non-obstructive disease and coronary vasomotor dysfunction...

On June 28, the House Committee on Energy and Commerce held a hearing on “Protecting America’s Seniors: Oversight of Private Sector Medicare Advantage Plans,”...

Elizabeth A. Jackson, MD,...

Quick Takes Maintain a high level of suspicion for cardiac sarcoidosis in the setting of sustained ventricular arrhythmias/sudden cardiac death, advanced AV block, and...